13 September,2021 08:39 PM IST | New Delhi | PTI
A vial of Covaxin
The World Health Organization's approval for the indigenous Covid-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said Monday.
The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China's Sinopharm and Oxford-AstraZeneca for emergency use.
Covaxin is one of the six vaccines that have received emergency use authorisation from India's drug regulator and is being used in the nationwide inoculation programme, alongwith Covishield and Sputnik V.
The Centre had told Rajya Sabha in July that all documents required for the WHO's Emergency Use Listing (EUL) have been submitted by Bharat Biotech as of July 9, and the global health body had commenced the review process.
ALSO READ
Mumbai man finds relief from Ankylosing Spondylitis after 30 yrs of chronic pain
India’s B2B2C mental health market likely to reach $3.9 billion by FY29
Consuming too much salt? It's harming your health, say experts
Four children among six injured in attack on Gaza vaccination centre
India has one of the highest levels of treatment coverage for tuberculosis: WHO
Also read: Covaxin single-dose to Covid-19 infected equivalent to 2 doses for unaffected: ICMR
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.
